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During the last decade, several key molecules have been identiﬁed as essential components for the ﬁltration barrier function
of kidney glomerular podocytes. Mutations in genes encoding these molecules severely impair the podocyte architecture in the
aﬀected patients,leadingto the developmentofproteinuria. Extensive investigationshavebeen performed onthe function ofthese
molecules,which highlightsthe importance oftyrosine kinasesignalingin the podocytes. An Src familytyrosine kinase,Fyn, plays
a major role in this signaling pathway. Here, we review the current understanding of this important signal transduction system
and its role in the development and the maintenance of podocytes.
1.Introduction
One of the major roles of kidney glomerulus is to ﬁltrate
blood plasma to excrete noxious metabolites into urine. A
pair of kidneys ﬁltrates around two hundred liters of blood
a day, which is about ﬁfty times whole blood volume. The
glomerulus, the site of ﬁltration, consists of a cluster of cap-
illaries, which is surrounded by three layers; the endothelial
cells, the glomerular basement membrane (GBM), and the
highly branched glomerular visceral epithelial cells, called
podocytes [1–4]( F i g u r e1(a)). A number of podocyte
proteins are shown to be essential for glomerular ﬁltration
barrier function, indicating that podocytes play a major role
in the ﬁltration process.
Podocytes form primary protrusions that further extend
numerous foot processes. Foot processes from neighboring
podocytes interdigitate with each other and surround the
entire surface of the capillary loops. The molecular architec-
ture of these foot processes consists of highly organized actin
ﬁlaments and actin ﬁlament-binding proteins [5].These foot
processes are bridgedby a uniquecell adhesion structure, the
slit diaphragm (SD). It is SD that functions as a ﬁltration
barrier of glomerulus, allowing the passage of water and
solutes of low molecular weight from the capillary lumen to
the urinary space to form primitive urine, while restricting
theﬂuxofmacromolecules.Usefulmaterialsincludingwater,
ions, and other nutrients are reabsorbed from the primitive
urine through tubules into peritubular capillaries.
Components of SD have been identiﬁed by human and
mouse disease genetics (Figure 1(b)). Nephrin, a central
molecule of SD, was ﬁrst identiﬁed as a product of NPHS1
gene. The mutations in NPHS1 gene cause early onset of
heavy proteinuria and rapid progression to end-stage renal
disease (congenital nephrotic syndrome of the Finnish type)
[6, 7]. Nephrin is a transmembrane protein that belongs
to the immunoglobulin superfamily. Neph1 is structurally
related to Nephrin, and mice deﬁcient in Neph1 develop
proteinuria and die early after birth [8]. NPHS2,e n c o d i n g
the glomerularprotein podocin, is mutated in the autosomal
recessive steroid-resistant nephrotic syndrome [9]. Muta-
tions in ACTN4, coding for α-actinin-4, cause familial focal
segmental glomerulosclerosis (FSGS) [10]. Several other
molecules, including FAT1 and CD2AP, are also identiﬁed as
components of SD. The mutations in genes encoding these2 Journal of Signal Transduction
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Figure 1:Schematicdrawing ofslitdiaphragm(SD) ofkidneyglomerularpodocytes. (a) Thecapillaries ofkidneyglomeruliare surrounded
bythreelayers:theendothelialcells,theglomerularbasementmembrane(GBM),andthehighlybranchedglomerularvisceralepithelialcells,
called podocytes. The blood pressure drives the ﬁltration of blood plasma into the urinary space. Neighboring podocytes form a unique cell
adhesion structure called SD that functions as a ﬁltration barrier (enclosed by a circle). (b) Molecular structure of SD. The components of
SD shown in this schematic drawing of SD have been identiﬁed by human and mouse genetics.
molecules in human diseases or in genetically manipulated
mice result in similar phenotypic conditions: the ﬂattening
of foot processes (called eﬀacement) and the loss of SD
structure, leading to proteinuria ([7, 8, 11–13]r e v i e w e di n
references [1–4]).
Nephrin interacts with Neph1 and podocin, forming a
trimeric proteincomplex[14–17](Figur e1(b)).These trans-
membraneproteinsatSDfurtherinteract withthejunctional
scaﬀolding proteins, ZO-1 [18], CASK [19], and MAGI-1/2
[20, 21], α-actinin-4 [21] that anchor the SD complex to the
elaborate actin cytoskeletal networks. Most of these proteins
are crucial to both the development of the glomerulus and
the ﬁlter function of SD.
In addition to its role as a structural framework of the
ﬁltration barrier, SD also plays an important role as a sig-
naling platform [3, 4, 22]. Finminor patients, whose Nephrin
cytoplasmic domain is deleted, exhibit a disease phenotype
very similar to Nephrin null mutation [6], suggesting that
Nephrin functions as a key molecule in this signaling
complex. Indeed, Nephrin interacts with IQGAP [23], an
eﬀector protein of small GTPases Rac1 and Cdc42. Nephrin
and CD2AP also interact with phosphatidylinositol 3-kinase
(PI3-kinase) p85 subunit, which leads to an increased Akt
activity and a reduction in cell death induced by apoptotic
stimuli [24]. There are also lines of evidence that tyrosine
phosphorylation may play a key role in the integrity of SD as
described below.
2.Tyrosine Phosphorylationof Nephrinby Fyn
A signiﬁcant portion of Nephrin resides in detergent resis-
tant membrane fraction (DRM) [25, 26]. An antibody
against podocyte-speciﬁc 9-O-acetylated GD3 ganglioside
can immunoisolate Nephrin in DRM. Interestingly, in vivo
administration of this antibody could induce eﬀacement
of SD, a hallmark of SD impairment, with a concomitant
tyrosine phosphorylation of Nephrin [25]. In cultured cells,
cross-linking of Nephrin with primary and secondary anti-
bodies also induces Nephrin tyrosine phosphorylation [27].
Several nonreceptor tyrosine kinases including Src, Yes, Lyn,
andFynareexpressedinapodocyte-derivedcellline,NPH15
[27] .T h e s et y r o s i n ek i n a s e sc a np h o s p h o r y l a t eN e p h r i n ,
when coexpressed with Nephrin in cultured cells [27, 28].
The disruption offyn genecausesproteinuria [29]. Using
genetically engineered mice, Verma et al. clearly showed that
Fyn is responsible for the phosphorylation of Nephrin in
podocytes [26]. In vitro phosphorylation of Nephrin in
the DRM fraction isolated from glomeruli of fyn−/− mice
showed a greatly decreased tyrosine phosphorylation of
Nephrin compared to that from wild-type mice. Fyn also
bindsto Nephrin in glomeruli. Furthermore, thestructure of
SD is severely impaired in fyn−/− mice [26]. Simultaneous
disruption of another tyrosine kinase gene, yes,d r i v e st h e
phenotype severer, suggesting that Yes has an auxiliary role.
These observations show that Fyn is a primary kinase for the
tyrosine phosphorylation of Nephrin in vivo [26].
3.NckLinksNephrinto ActinPolymerization
In 2006, two groups independently reported that phospho-
rylation of Nephrin cytoplasmic domain recruits an SH2
(Src homology 2)-SH3 containing adaptor protein, Nck
[30, 31]. Nck binds to phosphorylated tyrosine residues,
Y1191,Y1208,andY1232ofNephrin(residuesarenumbered
based on the mouse Nephrin sequence, accession number
AAK38483). Amino acid sequences surrounding all of these
three tyrosine residues fulﬁll the preferential binding motif
for Nck SH2 (Tyr-Asp-X-Val) [32], and these residues
are phosphorylated by Fyn in vitro [30, 33]. It is well
documented that Nck plays an essential role in the initiation
of actin polymerization. Nck has one SH2 and three SH3
domains.Byrecruitingmorethan20SH3bindingproteinsto
activated receptors or substrates for the activated receptors,
Nck regulates dynamic actin cytoskeletal organization and
motogenic responses (reviewed in reference [34]) (Figure 2).
Forexample,IRS-1andSosare involvedin thestimulation of
cell growth and WASp and Pak are major regulators of actin
cytoskeleton.Journal of Signal Transduction 3
Nck Grb2
Arp2/3
Nephrin
Neph1
Fyn Fyn
?
Soluble factor?
WASp
Cell-to-cell signal?
Figure 2: Nephrin and Neph1 cooperatively trigger actin polymerization. Upon tyrosine phosphorylation by Fyn, Nephrin and Neph1
recruit Nck and Grb2, respectively, that jointly initiate actin polymerization. For details, see text.
Nck has closely related two members, Nck1 and Nck2,
both of which are expressed in podocytes. Consistently, mice
lackingeitherNck1 orNck2 are viablewithoutapparentrenal
defects, and those lacking both genes are embryonic lethal
at day 9.5 [31]. Therefore, Jones et al. selectively disrupted
Nck2 in podocytes by means of Cre-loxP system in Nck1−/−
background [31]. These mice developed proteinuria and
focal sclerosis in glomeruli after birth. Electron microscopic
examination of four-day-old pups’ kidney revealed complete
fusion of foot processes, that is, the loss of SD structure.
ClusteringofNephrinexpressed inmouseembryonicﬁbrob-
lasts from Nck1−/−Nck2−/− mice induced localized actin
polymerization in a coexpressed Nck2-dependent manner
[31]. Nck function is still necessary even in adult mice,
because inducible deletion of Nck in podocytes results in
proteinuria, glomerulosclerosis, and altered morphology of
foot processes [42].
WASp/Scar proteins are important regulators of actin
cytoskeleton that promote actin ﬁlament nucleation and
branching by direct binding of their C termini to the
actin-related protein 2 and 3 (Arp2/3) complex [43]. The
interaction of WASp/Scar proteins with the Arp2/3 complex
is regulated by a number of activators, including the
Rho-family GTPases, phosphoinositides, and SH3 domains
[44]. Nck SH3 domains can induce, in cooperation with
phosphatidylinositol 4,5-bisphosphate (PIP2),full activation
o fa c t i nn u c l e a t i o ni na nin vitro reconstituted system
containing N-WASp-Arp2/3 complexes in the absence of
Cdc42 [45]. An essential role of Nck in mediating pathogen-
induced actin ﬁlament assembly in vivo is also shown [46].
The role of ligands of tyrosine kinase receptors is to
dimerize the receptors to activate their tyrosine kinase
activity [47]. Consistent with this notion, it is known that
antibodiesagainsttheextracellulardomainoftyrosinekinase
receptors can mimic the role of their native ligands. As to
Nephrin, however, the application of the primary antibody
againstNephrinaloneisnotsuﬃcientforNephrintobecome
tyrosine phosphorylated [27]. In addition, the secondary
antibody against the primary antibody is necessary, indicat-
ing that clustering/aggregation of Nephrin is required to be
phosphorylated by Fyn. Under such conditions, the local
concentration of Nck recruited to clustering Nephrin may
become high enough to induce actin polymerization. In
this respect, it is worth mentioning that a chimeric protein
consisting of extracellular and transmembrane domain from
CD16 and CD7, respectively, fused to Nck is suﬃcient to
induce actin polymerization upon clustering [48]. However,
the timing and the location of Nephrin phosphorylation,
Nck recruitment, and following actin polymerization in
vivo still remain unclear at present. Therefore, this possi-
bility requires further examination in experimental animal
models. Verma et al. reported that strong phospho-Nephrin
signal is observed in developing glomeruli of mice, whereas
it becomes weaker in adult tissues [30]. This observation
suggests that Nephrin phosphorylation is required for the
initiation of actin polymerization during junctional forma-
tion.
Besides Nck-dependent regulation of actin polymeriza-
t i o n ,N e p h r i nm a ya l s or e g u l a t ea c t i nd y n a m i c sb yo t h e r
signaling pathways. Nephrin directly binds to IQGAP1 [23],
an eﬀector of Rac and Cdc42 that are involved in a wide
range of cell biological processes, such as cell motility,
polarity formation, and morphology [49]. Nephrin and
CD2AP collaboratively control PI3-kinase-Akt pathway. In
addition to suppressing proapoptotic signals [24], recent
ﬁndings highlighted the role of PI3-kinase regulation of4 Journal of Signal Transduction
an actin ﬁlament-severing factor, coﬁlin1 [50, 51]. Nephrin
activation induced an activation of coﬁlin1 (dephosphory-
lation of coﬁlin1), through the activation and inactivation
of PI3-kinase and LIMK (LIM domain containing kinase),
respectively. Podocyte-speciﬁc targeting of Cﬂ1 in mice re-
sulted in persistent proteinuria by 3 months of age [50].
Coﬁlin1 deﬁciency led to foot process eﬀacement and
proteinuria in zebraﬁsh, and an accumulation of F-actin
ﬁbers and signiﬁcantly decreased podocyte migration ability
inculturedmousepodocytes[51].Interestingly, unphospho-
rylated active coﬁlin1 was distributed throughout the cells
in normal kidney tissues, whereas coﬁlin1 was inactivated
by phosphorylation and observed in the nuclei of podocytes
under glomerular disease conditions [51].
4.Collaborationof Nephrinand Neph1 in
ActinPolymerization
Nephrininteracts with Neph1 by their cytoplasmic domains.
In addition, Nephrin extracellular domain interacts with
itself and Neph1 via a transinteraction between the adjacent
foot processes [15, 16]. Neph1 is also a substrate for Fyn and
binds Grb2 upon phosphorylation [40, 41]. Grb2 is another
SH2-SH3 adaptor protein, recruiting SH3-binding partners
to plasma membrane. Unlike Nephrin that interacts with
Nck at three binding sites, Neph1 seems to provide only one
binding site for Grb2 [40, 41].
Garg et al. constructed a chimeric protein consisting of
CD16 extracellular and CD7 transmembrane domains and
Neph1 cytoplasmic domain (CD16/CD7/Neph1CD), and
expressed the chimeric protein in NIH3T3 cells. Similar to
Nephrin clustering, CD16/CD7/Neph1CD became tyrosine
phosphorylated upon clustering and recruited Grb2, which
triggered actin polymerization at the clustered sites. Neph1
phosphorylation requiredFyn,since Neph1phosphorylation
did not occurin mouse embryonic ﬁbroblasts obtained from
src−/−yes−/−fyn−/− mice, which was rescued by transduc-
tion of fyn gene [40]. Because NIH3T3 cells do not express
Nephrin, this clustering-induced phosphorylation of Neph1
seems to be Nephrin independent. Actin polymerization
induced by Nephrin clustering was signiﬁcantly augmented
by co-expression of Neph1 suggesting their cooperative roles
[40]( F i g u r e2). Since Nephrin and Neph1 interact each
other, Nck and Grb2 may be positioned on the plasma
membrane side by side at rather high concentrations. Inter-
estingly, vaccinia virus has a similar actin polymerization
mechanism. The viral protein A36R is tyrosine phospho-
rylated by Fyn that results in the recruitment of both Nck
and Grb2 that cooperate to induce localized actin ﬁlament
polymerization [52].
5.Tyrosine KinaseSignaling, YetMore
Other SH2 containing molecules including Crk, ShcA, Fyn,
p85 subunit of PI3-kinase, PLC-γ1, and Crk-L also bind to
tyrosine phosphorylated but not unphosphorylated Nephrin
[24, 30, 33]( F i g u r e3). PI3-kinase/Akt pathway also con-
trols actin dynamics through a small GTPase Rac [53].
Stable transfection of rat Nephrin in the podocytes with
podocin led to Nephrin tyrosine phosphorylation, PI3-
kinase-dependent phosphorylation of Akt, increased Rac1
activity, and an altered actin cytoskeleton with decreased
stress ﬁbers and increased lamellipodia [53]. Crk also
regulates cell adhesion to the basement membrane in collab-
oration with p130Cas by a C3G-Rap1 pathway in ﬁbroblasts
[54]. ShcA and PLC-γ are common players that mediate
signals from various tyrosine kinase receptors. As in these
systems, the binding of PLC-γ to phosphorylated Nephrin
triggers calciumsignaling pathways [33]. Aphospho-peptide
surrounding Nephrin Y1208 could precipitate PLC-γ 1f r o m
the cell lysates. However, this result does not exclude the
possibility that some factor mediates the association between
Nephrin and PLC-γ 1. Mutations in PLC-ε1g e n ea l s o
cause early-onset nephrotic syndrome [55], suggesting an
important role of calcium signaling in podocytes.
Tyrosine phosphorylation of Nephrin may also regulate
the turnover of Nephrin. Nephrin is rapidly subjected to
clathrin-mediated endocytosisorclathrin-independent,raft-
mediated endocytosis [56]. Interaction of Nephrin with
β-arrestin2 is diminished by phosphorylation of Y1208,
which may result in the attenuation of clathrin-mediated
endocytosis of Nephrin [57]. In contrast, Y1191F/Y1208F
mutant of Nephrin lacking major phosphorylation sites is
endocytosed at a slower rate than wild-type Nephrin in a
raft-mediated manner, suggesting that phosphorylation of
these sites augments the raft-mediated internalization [56].
Whether internalized Nephrin is still active in the signaling
or whether recycling of Nephrin occurs or not awaits further
experiments.
The recruitment of Grb2 may serve another function.
Contrary to our expectation that the recruitment of Grb2
to the plasma membranes activates Ras/Erk pathway, Neph1
binding of Grb2 suppressed the activation of ERK [41].
Similar suppression of Erk activation by sprouty [58]o r
Dok-3 [59] is described. These molecules, when tyrosine
phosphorylated, bind to Grb2 and may sequestrate Grb2/Sos
complex into a compartment where Ras does not exist.
It is, thus, possible that the Neph1 and Ras are localized
in diﬀerent membrane compartments, which needs to be
conﬁrmed by further experiments. Neph1 also binds CSK
upon phosphorylation likely through its SH2 domain [41].
CSK is a member of Src family tyrosine kinase (SFK)
that negatively regulates SFKs by phosphorylating their
regulatory tyrosine residue [60]. Like Nephrin and Neph1,
CSK is shown to reside in lipid raft [60]. The physiological
meaning of this Neph1-CSK interaction is to be clariﬁed.
6.Phosphorylationof SDComponentsduring
InjuryofPodocytes
Proteomic analysis of glomeruli reveals that several SD
components including Nephrin, Neph1, signal-inhibitory
regulatory protein (SIRP)-α)SHPS-1), FAK1, and paxillin
a r et y r o s i n ep h o s p h o r y l a t e dt os o m ee x t e n ti nn o r m a l
glomeruli of adult rats [61]. But, how are SD components
tyrosine phosphorylated? Or when their phosphorylation
level is altered? This most important issue is still open to beJournal of Signal Transduction 5
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Figure 3: Signaling molecules in SD. In addition to Nck and Grb2 recruitment in Figure 2, Nephrin and Neph1 bind to signaling molecules
shown in the ﬁgure to regulate a variety of cellular events.
Table 1: Summary of the studies on Nephrin and Neph1 phosphorylation under disease conditions.
Antibodies Phosphorylationin animal models Phosphorylationin humann diseases Reference
Nephrin
1208 and 1232 Decrease in PAN Decrease in MCNS [35]
1208 and 1232 Slight decrease in MN [36]
1232 Decrease in PAN [35]
pTyr Decrease in PAN [37]
1191/1208 Decrease in LPS [38]
1191/1208 Decrease in c-mip∗ [38]
1191/1208 Increase in PAN [30]
1208 Increase in PS [30]
1208 Increase in PS [33]
pTyr Increase in 27A∗∗ [25]
pTyr Increase in PHN [39]
Neph1 pTyr Increase in PAN [40]
637/638 Increase in PAN, PS [41]
The numbers in the column “antibodies”mean the site of phosphorylation based on the mouse Nephrin sequence(accession number AAK38483).“1208 and
1232” means separate antibodies and “1191/1208” antibody recognizes both phosphorylaion sites. pTyr means commercial antiphosphotyrosine antibodies.
PAN:puromycinaminonucleoside;LPS: lipoporysaccharide;PS:protamine sulfate;PHN:passive Heymannnephritis.MCN: minimalchange nephrosis; MN:
membranous nephropathy. ∗Mice overexpressing c-mip; ∗∗mice injected with 27A antibody against podocyte-speciﬁc 9-O-acetylated GD3 ganglioside.
investigated. Although clustering/aggregation of Nephrin
induces Fyn-dependent phosphorylation in cultured cells,
and this procedure may not reﬂect the pathogenesis of
podocyte damage observed in vivo. Nephrin molecules
interact with each other not only in cis (side by side)
but also in trans (head-to-head) orientation [15]. Antibody
cross-linking could reﬂect only the lateral assembly of
Nephrin. Molecular basis for in vivo phosphorylation and
dephosphorylation of Nephrin is thus still unclear; however,
phosphorylation level of SD components has been investi-
gated in various situations in vivo.
Uchida et al. reported that phosphorylation of Nephrin
in glomeruli of patients with minimal change nephrosis
(MCN) is signiﬁcantly decreased compared with that in
normal glomeruli [35]( T a b l e1). The same study group
also examined Nephrin phosphorylation in patients with
membranous nephropathy (MN) [36]. A decrease in the
immunoﬂuorescent intensity of phospho-Nephrin is not
observedin stageI, and only a slight decrease isseen in stages
II, III, and IV compared with controls. However, no sig-
niﬁcant correlation between Nephrin phosphorylation and
proteinuria is observed [36].
Nephrin and Neph1 has been examined in several
animal models that induce protein uria. However, incon-
sistent results are published so far (Table 1). Uchida et al.
observed that Nephrin phosphorylation was visible before
the puromycin aminonucleoside (PAN-) induced nephrosis,
which became undetectable during the disease induction,6 Journal of Signal Transduction
with a concomitant decrease in ﬁlamentous actin contents
[35]. Joneset al. [42]a n dL ie ta l .[ 37] also observed a similar
decrease using the same animal model. On the other hand,
Garg et al. [40]a n dH a r i t ae ta l .[ 41]o b s e r v e da ni n c r e a s ei n
the phosphorylation of Nephrin and Neph1 in PAN-induced
nephrosis.
Recently, an adaptor protein, c-mip has received much
attention [38]. c-mip, expression is invisible in healthy kid-
ney whereas its expression is signiﬁcantly upregulated in
patients with MCN and MN. Interestingly, c-mip inhibits
interactions between Fyn and the cytoskeletal regulator
N-WASP (neural Wiskott-Aldrich syndrome protein) and
between the adaptor protein Nck and Nephrin, which may
account for the cytoskeletal disorganization and the eﬀace-
mentoffootprocesses,inmiceorculturedpodocytesoverex-
pressing c-mip, phosphorylation of Nephrin decreases [38].
The same study also demonstrates that Nephrin phosphory-
lation also decreases in glomeruli injured by lipopolysaccha-
ride treatment [38].
In other experimental models such as protamine sulfate-
nephritis or passive Heymann nephritis, opposite results
are reported [25, 30, 33, 39, 41]. Perfusion of mouse
kidneys with protamine sulfate (PS) results in foot pro-
cess eﬀacement within 15min after the perfusion, while
subsequent perfusion with heparin sulfate largely restores
thenormal podocytemorphology.Nephrinphosphorylation
was observed in the podocytes of PS-perfused kidneys,
which is rapidly reversed after heparin sulfate perfusion
[30]. We observed similar upregulation in the tyrosine
phosphorylation of Nephrin, Neph1, and PLC-γ1i nP S -
perfused glomeruli ([33, 41], and Harita et al., unpublished
results). The PS-induced phosphorylation sites are identical
to those phosphorylated by Fyn [30, 33, 41]. Li et al.
described the increase in both Nephrin phosphorylation and
activity of Src family kinases in passive Heymann nephritis.
These seemingly contradictory results may reﬂect diﬀerences
in the experimental conditions. Progression of podocyte
damage may diﬀer among the animal models, therefore,
the changes in the intracellular signaling responding to
the damage may also diﬀer. The speciﬁcity and sensitivity
of antibodies used in these studies may also account for
the diﬀerence. Commercial antiphosphotyrosine antibod-
ies (pTyr) were used in some studies [37, 39, 40, 42],
whereas homemade site-speciﬁc antibodies were used in
other studies [30, 33, 35, 36, 38, 40–42]. Phosphorylation
of Nephrin in human specimen is investigated in only a
subset of nephrotic syndromes. Therefore, detailed analyses
of various types of the disease, and the speciﬁc animal
model that mimics each type of the disease, is necessary
to clarify the phosphorylation status under the disease
conditions.
7.ProteinTyrosine Phosphatasesin Podocytes
In vitro treatment of podocytes with pervanadate, an
inhibitorofproteintyrosinephosphatases,inducesstructural
changes of actin cytoskeleton and focal contact similar to
thoseinducedbyin vivoapplicationofPSorPAN,suggesting
that protein tyrosine phosphatases (PTPs) also regulate the
podocyte process structure [37]. Podocytes express several
protein tyrosine phosphatases, SHP-1/2, PTP-PEST, PTP-
1B, PTP-36, and GLEPP1/PTPro [61–64]. GLEPP1/PTPro
depletion in mice decreases the glomerular ﬁltration rate
with a change in podocyte morphology [63], and antibodies
to GLEPP1/PTPro increase the permeability of albumin of
isolated glomeruli in vitro [64], suggesting protein tyrosine
phosphatases also modulate thepodocyteﬁltration function.
SIRP-α, a type I transmembrane glycoprotein, that recruits
SHP-1/2 to the plasma membrane, is concentrated in
SD of podocytes [65]. These results suggest that tyrosine
phosphatases also play a signiﬁcant role to maintain the
appropriate phosphorylation level of SD components.
Our preliminary results have shown that tyrosine phos-
phorylation of Nephrin, Neph1,and PLC-γ1i si n v e r s e l yc o r -
related with that of SIRP-α during rat PS-induced podocyte
injury models ([33, 41], and Harita et al. unpublished
results). After the perfusion of PS, tyrosine phosphorylation
of these proteins was signiﬁcantly induced whereas the
intense phospho-SIRP-α signal observed prior to the PS
treatment became invisible. One possible scheme is that
SHP-1/2 may detach from SIRP-αupon dephosphorylation
of SIRP-α, shifting the phosphorylation/dephosphorylation
balance toward phosphorylation, which may induce the
phosphorylation of these molecules.
8.CalciumSignalingControlledby
Tyrosine Phosphorylation
PLC-γ1 binds to tyrosine phosphorylated Nephrin. The
binding site of PLC-γ1 is Y1208, which is identical to
one of the Nck binding sites [33]. Upon binding to
tyrosine phosphorylated Nephrin PLC-γ1 becomes tyrosine
phosphorylated and activated, with a concomitant increase
in the inositol-1,4,5-tris phosphate (IP3) and intracellular
calciumconcentration[Ca2+]i[33].IP3isknowntomobilize
calcium from the internal stores, which triggers calcium
eﬄux from the extracellular space. PLC-γ may also regulate
actin dynamics by its product, phosphatidylinositol 4,5-
bisphosphate (PIP2) [66]. Mutations in PLC-ε1g e n ec a u s e
renal failure, suggesting an essential role of phosphoinositide
signaling pathways in podocytes [55]. PLCE1 binds to
IQGAP1, which is a binding partner of Nephrin [21]. PLC-
ε1 gene expression begins in the developing glomerulus
at rather early stage (S-shaped stage) of glomerular devel-
opment and highly expressed during the early capillary
loop stage. Morpholino oligonucleotide-mediated knock-
down of PLC-ε1 caused to nephrotic syndrome in zebraﬁsh
[55].
Podocyte damage can be caused by a variety of Ca2+-
stimulating vasoactive hormones, including angiotensin II,
bradykinin, and endothelin, through altering the glomerular
ultraﬁltration coeﬃcient by Ca2+- and cAMP-dependent
signals [67]. Recent ﬁnding that mutations in TRPC6 gene
are associated with a human proteinuric kidney disease,
focal segmental glomerulosclerosis (FSGS) [68, 69]a l s o
links calcium signaling to podocyte injury. In this disease,Journal of Signal Transduction 7
podocytes and the SD lose their integrity, disrupting the
glomerular ﬁltration barrier [2–4]. TRPC6 is one of the
mammalian homologues of Drosophila transient receptor
potential canonical, the TRPCs, which are potent plasma
membrane channels that contribute to changes in the
cytosolic-free Ca2+ concentration, either by acting as Ca2+
entry pathways on the plasma membrane or by modulating
themembranedri vingf or c ef orCa 2+ entrythroughchanging
t h em e m b r a n ep o t e n t i a l[ 70–72]. These proteins form a
nonselective cation channel that is activated by receptor
stimulation orby the exogenousapplication ofdiacylglycerol
analogs. Among the seven mammalian TRPC channels, a
s u b f a m i l yo fT R P C 3 ,6 ,7c a nb ed e ﬁ n e db yt h e i rs i m i l a r i t y
in the primary structure and function.
Whereas the mode of heredity of NPHES1 (Nephrin)
and NPHES2 (podocin) muatiions is recessive, the dis-
ease causing mutations of TRPC6 gene are inherited in
an autosomal dominant manner, which suggests that the
mutations may enhance the channel activity. Increased
expression of wild-type TRPC6 is also a common feature
of human proteinuric kidney diseases [73]. While overex-
pression of both wild and mutant TRPC6 in podocytes
in mice induces proteinuria [74], how the disease-causing
mutations aﬀect the channel activity of TRPC6 remains
unclear. Some mutations (P112Q, R895C, E897K) enhance
angiotensin II receptor-mediated activation of TRPC6 when
expressed in HEK293 cells, while neither the S270T nor the
N143S missense mutations, nor a 57-amino acid truncation
mutation (K874X), altered the channel activity [68, 69].
These channel activities correlated well with the extent
of downstream NFAT activation, mediated by a calcium
dependent phosphatase, calcineurin [75]. On the other
hand, the P112Q mutation increased the plasma membrane
expression of TRPC6 [68], suggesting changes in surface
expression may also contribute to the pathogenesis of the
disease.
Our recent unpublished ﬁndings concerning the role of
TRPC6 phosphorylation may shed lights on this apparently
puzzling issue (Kanda et al. unpublished data). Fyn also
phosphorylates TRPC6 and enhances its channel activity
[76].Uponphosphorylation byFynatY31and Y284,TRPC6
forms a complex with PLC-γ1. This complex formation is
criticalforTRPC6totranslocate fromcytoplasmicvesiclesto
the surface of plasma membrane, because siRNA-mediated
downregulation of RLC-γ1 abolished the TRPC6 surface
expression. Concomitant with this translocation, TRPC6
channel activity was enhanced. We also found that Nephrin
binds to phosphorylated TRPC6, interfering with TRPC6-
PLC-γ1 complex formation and subsequent translocation
to the plasma membrane. Y284 of TRPC6 is also critical
for Nephrin-TRPC6 complex formation. TRPC6 expression
did not aﬀect on Nephrin phosphorylation (either wild-type
or mutants). Importantly, all the disease-causing mutations
dramatically reduce the aﬃnity of TRPC6 to Nephrin,
which renders mutant TRPC6s insensitive to Nephrin sup-
pression. Therefore, the proportion of surface expressed
mutant TRPC6s is much higher than that of the wild-type
channel, which may cause exaggerated calcium signaling in
podocytes.
9.Conclusion
Kidney glomerular podocytes form an elaborate cell-to-cell
adhesion structure called the slit diaphragm (SD) between
adjacent podocytes. SD not only functions as a ﬁltration
barrier, but also plays an important role as a signaling
scaﬀold. Human and mouse genetics as well as biochemical
and cell biological studies have identiﬁed a variety of
SD components. The disruption of genes encoding these
components cause proteinuria in aﬀected human patients
and mice.
Tyrosine phosphorylation is a fundamental reaction that
controls the integrity and function of SD. A tyrosine kinase,
Fyn, phosphorylates several SD components including
Nephrin, Neph1, and TRPC6. Upon phosphorylation,
Nephrin recruits an adaptor protein Nck, which initiates
actin polymerization. Neph1 also collaborates with Nephrin
by recruiting another adaptor protein Grb2. Nephrin and
Neph1 also bind to a wide range of signaling molecules upon
tyrosine phosphorylation such as PLC-γ1, ShcA, PI3-kinase,
Crk, and CSK, which induces further signaling to down-
stream molecules. Protein tyrosine phosphatases may also
participateinthistyrosine phosphorylationsignalingsystem.
In vivo conditions where tyrosine phosphorylation
occurs still remain to be investigated. The most important
i s s u ei st h e nt oe l u c i d a t et h em o l e c u l a rm e c h a n i s mf o rt h e
regulation of Fyn activity; what kinds of signals do control
Fyn? Cell-to-cell interaction, some soluble factors, signals
from the basement membrane, or cell-intrinsic signals?
Insights into these questions may provide us the basis for the
development of therapeutic approaches in future.
Lines of evidence suggest that oversignaling of calcium
is toxic to podocytes. Mutations aﬀecting TRPC6 calcium
channel are found in patients with FSGS, which further sup-
ports the involvement of calcium signaling in the podocyte
damage.Ourunpublishedresultshaveshown thatthedisease
causing mutations of TRPC6 signiﬁcantly reduce the aﬃnity
of TRPC6 with Nephrin and promote its surface expression
and channel activity, which may resultin the oversignaling of
calcium.
Acknowledgments
Our studies cited in this paper are supported in part by
Grants-in-Aid for Scientiﬁc Research (B) from the Japan
Society for the Promotion of Science (JSPS) (to S. Hattori),
Grant-in-Aid from the Japan Society for the Promotion of
Science Fellows from JSPS (to S. Kanda), and Grant-in-Aid
for Young Scientists (B) (20790719, 22790991) (to Y. Harita)
from the Ministry of Education,Culture, Sports, Scienceand
Technology of Japan. The authors also thank Keiko Hattori
for critical reading of the manuscript.
References
[1] H. Pavenstadt, W. Kriz, and M. Kretzler, “Cell biology of the
glomerularpodocyte,” Physiological Reviews,v ol.83,no .1,p p .
253–307, 2003.8 Journal of Signal Transduction
[2] K. Tryggvason, J. Patrakka, and J. Wartiovaara, “Hereditary
proteinuria syndromes and mechanisms of proteinuria,” The
New England Journal of Medicine, vol. 354, no. 13, pp. 1387–
1401, 2006.
[3] J. Patrakka and K. Tryggvason, “New insights into the role of
podocytes in proteinuria,” Nature Reviews Nephrology,v o l .5 ,
no. 8, pp. 463–468, 2009.
[ 4 ] M .M .L¨ owik,P. J.Groenen, E. N. Levtchenko, L. A. Monnens,
and L. P. van den Heuvel, “Molecular genetic analysis of
podocyte genes in focal segmental glomerulosclerosis—a
review,” European Journal of Pediatrics, vol. 168, no. 11, pp.
1291–1304, 2009.
[5] D. Kerjaschki, “Caught ﬂat-footed: podocyte damage and
the molecular bases of focal glomerulosclerosis,” Journal of
Clinical Investigation, vol. 108, no. 11, pp. 1583–1587, 2001.
[6] M. Kestil¨ a ,U .L e n k k e r i ,M .M ¨ annikk¨ o et al., “Positionally
cloned gene for a novel glomerular protein—nephrin—is
mutated in congenital nephrotic syndrome,” Molecular Cell,
vol. 1, no. 4, pp. 575–582, 1998.
[7] H. Putaala, R. Soininen, P. Kilpel¨ ainen, J. Wartiovaara, and
K. Tryggvason, “The murine nephrin gene is speciﬁcally
expressed in kidney, brain and pancreas: inactivation of the
geneleads to massiveproteinuria andneonataldeath,”Human
Molecular Genetics,vol. 10, no. 1, pp. 1–8, 2001.
[8] D. B. Donoviel, D. D. Freed, H. Vogel et al., “Proteinuria and
perinatallethalityinmicelackingNEPH1,anovelproteinwith
homology to NEPHRIN,” Molecular and Cellular Biology,v o l .
21, no. 14, pp. 4829–4836, 2001.
[9] N .Bou t e ,O .G rib ou v al,S.R ose llie tal. ,“ N PH S2,e nc od ingt he
glomerularprotein podocin, ismutatedinautosomalrecessive
steroid-resistant nephrotic syndrome,” Nature Genetics,v o l .
24, no. 4, pp. 349–354, 2000.
[ 1 0 ]J .M .K a p l a n ,S .H .K i m ,K .N .N o r t he ta l . ,“ M u t a t i o n si n
ACTN4,e n c o d i n gα-actinin-4, cause familial focal segmental
glomerulosclerosis,” Nature Genetics, vol. 24, no. 3, pp. 251–
256, 2000.
[11] N. Y. Shih, J. Li, V. Karpitsk II et al., “Congenital nephrotic
syndrome in mice lacking CD2-associated protein,” Science,
vol. 286, no. 5438, pp. 312–315, 1999.
[12] L. Ciani, A. Patel, N. D. Allen, and C. Ffrench-Constant,
“MicelackingthegiantprotocadherinmFAT1exhibitrenalslit
junction abnormalities and a partially penetrant cyclopia and
anophthalmiaphenotype,”Molecular andCellular Biology,v ol.
23, no. 10, pp. 3575–3582, 2003.
[13] S.Roselli, L.Heidet, M.Sichet al.,“Early glomerularﬁltration
defect and severe renal disease in podocin-deﬁcient mice,”
Molecular and Cellular Biology, vol. 24, no. 2, pp. 550–560,
2004.
[14] K. Schwarz, M. Simons, J. Reiser et al., “Podocin, a raft-
associated component of the glomerular slit diaphragm,
interacts with CD2AP and nephrin,” Journal of Clinical
Investigation, vol. 108, no. 11, pp. 1621–1629, 2001.
[ 1 5 ]G .M .B a r l e t t a ,I .A .K o v a r i ,R .K .V e r m a ,D .K e r j a s c h k i ,
and L. B. Holzman, “Nephrin and Neph1 co-localize at the
podocyte foot process intercellular junction and form cis
hetero-oligomers,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y , vol. 278,
no. 21, pp. 19266–19271, 2003.
[16] P. Gerke, T. B. Huber, L. Sellin, T. Benzing, and G. Walz,
“Homodimerization and heterodimerization of the glomeru-
lar podocyte proteins nephrin and NEPH1,” Journal of the
American Society of Nephrology, vol. 14, no. 4, pp. 918–926,
2003.
[17] L.Sellin,T. B.Huber, P.Gerke, I.Quack,H.Pavenst¨ adt,andG.
Walz, “NEPH1 deﬁnes a novel family of podocin interacting
proteins,”TheFASEBJournal,vol.17,no.1,pp.115–117,2003.
[ 1 8 ]T .B .H u b e r ,M .S c h m i d t s ,P .G e r k ee ta l . ,“ T h ec a r b o x y l
terminus of Neph family members binds to the PDZ domain
protein zonula occludens-1,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y ,
vol. 278, no. 15, pp. 13417–13421, 2003.
[ 1 9 ]N .Y .S h i ,J .L i ,R .C o t r a n ,P .M u n d e l ,J .H .M i n e r ,a n dA .S .
Shaw, “CD2AP localizes to the slit diaphragm and binds to
nephrin via a novel C-terminal domain,” American Journal of
Pathology, vol. 159, no. 6, pp. 2303–2308, 2001.
[20] S. Hirabayashi, M. Tajima, I. Yao, W. Nishimura, H. Mori,
and Y. Hata, “JAM4, a junctional cell adhesion molecule
interacting with a tight junction protein, MAGI-1,” Molecular
and Cellular Biology, vol. 23, no. 12, pp. 4267–4282, 2003.
[ 2 1 ]S .L e h t o n e n ,J .J .R y a n ,K .K u d l i c k a ,N .I i n o ,H .Z h o u ,a n d
M. G. Farquhar, “Cell junction-associated proteins IQGAP1,
MAGI-2, CASK, spectrins, and α-actinin are components of
thenephrinmultiproteincomplex,”ProceedingsoftheNational
Academy of Sciences of the United States of America, vol. 102,
no. 28, pp. 9814–9819, 2005.
[22] T. Benzing, “Signaling at the slit diaphragm,” Journal of the
American Society of Nephrology, vol. 15, no. 6, pp. 1382–1391,
2004.
[23] X. L. Liu, P. Kilpel¨ ainen, U. Hellman et al., “Characterization
of the interactions of the nephrin intracellular domain,” FEBS
Journal, vol. 272, no. 1, pp. 228–243, 2005.
[24] T. B. Huber, B. Hartleben, J. Kim et al., “Nephrin and CD2AP
associate with phosphoinositide 3-OH kinase and stimulate
AKT-dependent signaling,” Molecular and Cellular Biology,
vol. 23, no. 14, pp. 4917–4928, 2003.
[ 2 5 ]M .S i m o n s ,K .S c h w a r z ,W .K r i ze ta l . ,“ I n v o l v e m e n to fl i p i d
rafts in nephrin phosphorylation and organization of the
glomerular slit diaphragm,” American Journal of Pathology,
vol. 159, no. 3, pp. 1069–1077, 2001.
[26] R. Verma, B. Wharram, I. Kovari et al., “Fyn binds to
and phosphorylates the kidney slit diaphragm component
Nephrin,” Journal of Biological Chemistry, vol. 278, no. 23, pp.
20716–20723, 2003.
[27] J. Lahdenper¨ a, P. Kilpel¨ ainen, X. L. Liu et al., “Clustering-
induced tyrosine phosphorylation of nephrin by Src family
kinases,” Kidney International, vol. 64, no. 2, pp. 404–413,
2003.
[ 2 8 ]H .L i ,S .L e m a y ,L .A o u d j i t ,H .K a w a c h i ,a n dT .T a k a n o ,“ S r c -
family kinase Fyn phosphorylates the cytoplasmic domain of
nephrin and modulates its interaction with podocin,” Journal
of theAmerican SocietyofNephrology,vol.15,no.12,pp.3006–
3015, 2004.
[ 2 9 ]C .C .K .Y u ,T .S .B .Y e n ,C .A .L o w e l l ,a n dA .L .D e F r a n c o ,
“Lupus-like kidney disease in mice deﬁcient in the Src family
tyrosine kinases Lyn and Fyn,” Current Biology, vol. 11, no. 1,
pp. 34–38, 2001.
[ 3 0 ]R .V e r m a ,I .K o v a r i ,A .S o o ﬁ ,D .N i h a l a n i ,K .P a t r i e ,a n dL .
B. Holzman, “Nephrin ectodomain engagement results in Src
kinase activation, nephrin phosphorylation, Nck recruitment,
and actin polymerization,” Journal of Clinical Investigation,
vol. 116, no. 5, pp. 1346–1359, 2006.
[31] N. Jones, I. M. Blasutig, V. Eremina et al., “Nck adaptor
proteins link nephrin to the actin cytoskeleton of kidney
podocytes,” Nature, vol. 440, no. 7085, pp. 818–823, 2006.
[32] S. Gruenheid, R. DeVinney, F. Bladt et al., “Enteropathogenic
E. coli Tir binds Nck to initiate actin pedestal formation in
hostcells,”Nature CellBiology,vol.3,no.9,pp. 856–859,2001.Journal of Signal Transduction 9
[33] Y. Harita, H. Kurihara, H. Kosako et al., “Phosphorylation of
nephrin triggers Ca2+ signaling by recruitment and activation
of phospholipase C-γ1,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y ,v o l .
284, no. 13, pp. 8951–8962, 2009.
[34] W. Li, J. Fan, and D. T. Woodley, “Nck/Dock: an adapter
between cell surface receptors and the actin cytoskeleton,”
Oncogene, vol. 20, no. 44, pp. 6403–6417, 2001.
[35] K. Uchida, K. Suzuki, M. Iwamoto et al., “Decreased tyrosine
phosphorylation of nephrin in rat and human nephrosis,”
Kidney International, vol. 73, no. 8, pp. 926–932, 2008.
[36] T. Ohashi, K. Uchida, Y. Asamiya et al., “Phosphorylation sta-
tus of nephrin in human membranous nephropathy,” Clinical
and Experimental Nephrology, vol. 14, no. 1, pp. 51–55, 2010.
[ 3 7 ]H .L i ,J .Z h u ,L .A o u d j i te ta l . ,“ R a tn e p h r i nm o d u l a t e sc e l l
morphology via the adaptor protein Nck,” Biochemical and
Biophysical Research Communications, vol.349,no.1,pp. 310–
316, 2006.
[38] S. Y. Zhang, M. Kamal, K. Dahan et al., “C-mip impairs
podocyte proximal signaling and induces heavy proteinuria,”
Science Signaling, vol. 3, no. 122, p. ra39, 2010.
[ 3 9 ]H .L i ,S .L e m a y ,L .A o u d j i t ,H .K a w a c h i ,a n dT .T a k a n o ,“ S r c -
family kinase Fyn phosphorylates the cytoplasmic domain of
nephrin and modulates its interaction with podocin,” Journal
ofthe American SocietyofNephrology,vol.15,no.12,pp.3006–
3015, 2004.
[ 4 0 ]P .G a r g ,R .V e r m a ,D .N i h a l a n i ,D .B .J o h n s t o n e ,a n dL .B .
Holzman, “Neph1 cooperates with nephrin to transduce
a signal that induces actin polymerization,” Molecular and
Cellular Biology, vol. 27, no. 24, pp. 8698–8712, 2007.
[41] Y. Harita,H. Kurihara,H. Kosakoet al.,“Neph1, a component
of the kidney slit diaphragm, is tyrosine-phosphorylated by
the Src family tyrosine kinase and modulates intracellular
signaling by binding to Grb2,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y ,
vol. 283, no. 14, pp. 9177–9186, 2008.
[42] N. Jones, L. A. New, M. A. Fortino et al., “Nck proteins
maintainthe adultglomerularﬁltrationbarrier,” Journal of the
American Society of Nephrology, vol. 20, no. 7, pp. 1533–1543,
2009.
[43] S. Suetsugu, H. Miki, and T. Takenawa, “Spatial and temporal
regulation of actin polymerization for cytoskeleton formation
through Arp2/3 complex and WASP/WAVE proteins,” Cell
Motilityand theCytoskeleton,vol.51,no.3,pp. 113–122,2002.
[44] H. N. Higgs, “Actin nucleation: nucleation-promoting factors
are not all equal,” Current Biology, vol. 11, no. 24, pp. R1009–
R1012, 2001.
[45] R. Rohatgi, P. Nollau, H. Y. Henry Ho, M. W. Kirschner, and
B. J. Mayer, “Nck and phosphatidylinositol 4,5-bisphosphate
synergistically activate actin polymerization through the N-
WASP-Arp2/3 pathway,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y ,v o l .
276, no. 28, pp. 26448–26452, 2001.
[46] M. B. Goldberg, “Actin-based motility of intracellular micro-
bial pathogens,” Microbiology and Molecular Biology Reviews,
vol. 65, no. 4, pp. 595–626, 2001.
[47] M. A. Lemmon and J. Schlessinger, “Cell signaling by receptor
tyrosine kinases,” Cell, vol. 141, no. 7, pp. 1117–1134, 2010.
[ 4 8 ]G .M .R i v e r a ,C .A .B r i c e ˜ n o ,F .T a k e s h i m a ,S .B .S n a p p e r ,a n d
B. J. Mayer, “Inducible clustering of membrane-targeted SH3
domains of the adaptor protein Nck triggers localized actin
polymerization,” Current Biology, vol. 14, no. 1, pp. 11–22,
2004.
[49] S. Etienne-Manneville and A. Hall, “Rho GTPases in cell
biology,” Nature, vol. 420, no. 6916, pp. 629–635, 2002.
[50] P. Garg, R. Verma, L. Cook et al., “Actin-depolymerizing
factor coﬁlin-1 is necessary in maintaining mature podocyte
architecture,” J o u r n a lo fB i o l o g i c a lC h e m i s t r y , vol. 285, no. 29,
pp. 22676–22688, 2010.
[51] S. Ashworth, B. Teng, J. Kaufeld et al., “Coﬁlin-1 inactivation
leads to proteinuria—studies in zebraﬁsh, mice and humans,”
PLoS One, vol. 5, no. 9, Article ID e12626, 2010.
[52] N. Scaplehorn, A. Holmstr¨ am, V. Moreau, F. Frischknecht,
I. Reckmann, and M. Way, “Grb2 and Nck act cooperatively
to promote actin-based motility of vaccinia virus,” Current
Biology, vol. 12, no. 9, pp. 740–745, 2002.
[53] J. Zhu, N. Sun, L. Aoudjit et al., “Nephrin mediates actin
reorganization via phosphoinositide 3-kinase in podocytes,”
Kidney International, vol. 73, no. 5, pp. 556–566, 2008.
[54] A.Sakakibara,Y.Ohba,K.Kurokawa,M.Matsuda,andS.Hat-
tori, “Novel function of Chat in controlling cell adhesion via
Cas-Crk-C3G-pathway-mediated Rap1 activation,” Journal of
Cell Science, vol. 115, no. 24, pp. 4915–4924, 2002.
[ 5 5 ]B .H i n k e s ,R .C .W i g g i n s ,R .G b a d e g e s i ne ta l . ,“ P o s i t i o n a l
cloning uncovers mutations in PLCE1 responsible for a
nephrotic syndrome variant that may be reversible,” Nature
Genetics,vol. 38, no. 12, pp. 1397–1405, 2006.
[56] X. S. Qin, H. Tsukaguchi, A. Shono, A. Yamamoto, H.
Kurihara, and T. Doi, “Phosphorylation of nephrin triggers
itsinternalizationbyraft-mediated endocytosis,”Journal of the
American SocietyofNephrology,vol.20,no.12,pp. 2534–2545,
2009.
[ 5 7 ]I .Q u a c k ,L .C .R u m p ,P .G e r k ee ta l . ,“ β-arrestin2 mediates
nephrin endocytosis and impairs slit diaphragm integrity,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 103, no. 38, pp. 14110–14115, 2006.
[58] H. Hanafusa,S. Tor II, T. Yasunaga,and E. Nishida, “Sprouty1
and sprouty2provide a controlmechanism forthe Ras/MAPK
signallingpathway,”Nature CellBiology,vol.4,no.11,pp.850–
858, 2002.
[59] M. Honma,O. Higuchi, M. Shirakataet al., “Dok-3 sequesters
Grb2 and inhibits the Ras-Erk pathway downstream of
protein-tyrosine kinases,” Genes to Cells,v o l .1 1 ,n o .2 ,p p .
143–151, 2006.
[60] Y. P. Chong, T. D. Mulhern, and H. C. Cheng, “C-terminal
Src kinase (CSK) and CSK-homologous kinase (CHK)—
endogenous negative regulators of Src-familyprotein kinases,”
Growth Factors, vol. 23, no. 3, pp. 233–244, 2005.
[61] Y. Zhang, Y. Yoshida, M. Nameta et al., “Glomerular proteins
related to slit diaphragm and matrix adhesion in the foot
processes arehighlytyrosinephosphorylatedinthenormalrat
kidney,” NephrologyDialysis Transplantation, vol.25,no.6,pp.
1785–1795, 2010.
[ 6 2 ]J .R e i s e r ,F .J .P i x l e ,a n dA .H u g ,“ R e g u l a t i o no fm o u s e
podocyte process dynamics by protein tyrosine phosphatases
rapidcommunication,”Kidney International,vol.57,no.5,pp.
2035–2042, 2000.
[63] B. L. Wharram, M. Goyal, P. J. Gillespie et al., “Altered
podocyte structure in GLEPP1 (Ptpro)-deﬁcient mice asso-
ciated with hypertension and low glomerular ﬁltration rate,”
Journal of Clinical Investigation, vol. 106, no. 10, pp. 1281–
1290, 2000.
[64] S. Deane, R. C. Wiggins, M. Goyal et al., “Antibodies
to protein tyrosine phosphatase receptor type O (PTPro)
increase glomerular albumin permeability (Palb),” American
Journal of Physiology—Renal Physiology, vol. 297, no. 1, pp.
F138–F144, 2009.
[65] H. Kurihara, Y. Harita, and K. Ichimura, “SIRP-alpha-CD47
system functions as an intercellular signal in the renal
glomerulus,” American Journal of Physiology and Renal Phys-
iology, vol. 299, no. 3, pp. F517–F527, 2010.10 Journal of Signal Transduction
[66] G. Mouneimne, L. Soon, V. DesMarais et al., “Phospholipase
C and coﬁlin are required for carcinoma cell directionality in
response to EGF stimulation,”J o u r n a lo fC e l lB i o l o g y , vol. 166,
no. 5, pp. 697–708, 2004.
[67] H.Pavenst¨ adt,“Rolesofthepodocyte inglomerularfunction,”
American Journal of Physiology, vol.278,no. 2,pp. F173–F179,
2000.
[68] M. P. Winn, P. J. Conlon, K. L. Lynn et al., “Medicine: a
mutation in the TRPC6 cation channel causes familial focal
segmental glomerulosclerosis,” Science, vol. 308, no. 5729, pp.
1801–1804, 2005.
[69] J .R e ise r ,K .R .P olu ,C .C .M¨ olleretal.,“TRPC6isaglomerular
slit diaphragm-associated channel required for normal renal
function,” Nature Genetics,vol. 37, no. 7, pp. 739–744, 2005.
[70] J. Abramowitz and L. Birnbaumer, “Physiology and patho-
physiologyofcanonicaltransientreceptor potentialchannels,”
The FASEB Journal, vol. 23, no. 2, pp. 297–328, 2009.
[71] B. Nilius, G. Owsianik, T. Voets, and J. A. Peters, “Transient
receptor potential cation channels in disease,” Physiological
Reviews, vol. 87, no. 1, pp. 165–217, 2007.
[72] K. Kiselyov and R. L. Patterson, “The integrative function of
TRPC channels,” Frontiers in Bioscience, vol. 14, pp. 45–58,
2009.
[73] C. C. M¨ oller, C. Wei, M. M. Altintas et al., “Induction of
TRPC6 channel in acquired forms of proteinuric kidney
disease,” Journal of the American SocietyofNephrology, vol. 18,
no. 1, pp. 29–36, 2007.
[74] P.Krall,C.P.Canales,P.Kairathetal.,“Podocyte-speciﬁc over-
expression ofwild type or mutanttrpc6 in mice is suﬃcient to
cause glomerular disease,” PLoS One,v o l .5 ,n o .9 ,A r t i c l eI D
e12859, 2010.
[75] J. Schl¨ ondorﬀ,D .D e lC a m i n o ,R .C a r r a s q u i l l o ,V .L a c e y ,
and M. R. Pollak, “TRPC6 mutations associated with focal
segmental glomerulosclerosis cause constitutive activation of
NFAT-dependent transcription,” American Journal of Physiol-
ogy, vol. 296, no. 3, pp. C558–C569, 2009.
[76] C. Hisatsune, Y. Kuroda, K. Nakamura et al., “Regulation of
TRPC6 channel activity by tyrosine phosphorylation,”Journal
of Biological Chemistry, vol. 279, no. 18, pp. 18887–18894,
2004.